For Immediate Release: November 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a final rule, to amend the color additive regulations to increase the fees for …
For Immediate Release: October 08, 2024 Today, the U.S. District Court for the Eastern District of California entered a consent decree of permanent injunction against Rizo Lopez Foods Inc. (“Rizo Lopez Foods”), a California-based food manufacturer, and the …
For Immediate Release: February 16, 2016 On Friday, Feb. 12, U.S. District Judge Jon D. Levy of the District of Maine entered a consent decree of permanent injunction against Mill Stream Corporation, doing business as Sullivan Harbor Farm, and its former …
For Immediate Release: August 09, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA invites the public to register for the public meeting on the Development of an Enhanced …
For Immediate Release: August 09, 2024 Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening (anaphylaxis), in adult and …
For Immediate Release: July 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA is announcing the fiscal year (FY) 2025 user fee rates for importers approved to …
For Immediate Release: July 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to include initiation …
For Immediate Release: July 23, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally …
For Immediate Release: July 16, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced the revised final guidance Application User Fees for Combination Products. …
FDA News Release FDA, FTC Issue Warning Letters to Companies Selling Food Products Containing Delta-8 THC That Mimic Chips, Candies and Snacks from Popular National Brands For Immediate Release: July 16, 2024 Today, the U.S. Food and Drug Administration …
For Immediate Release: July 12, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Wednesday, the FDA issued a Letter to Health Care Providers to notify providers that we are aware the …
For Immediate Release: November 07, 2024 Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the temporary relief …
For Immediate Release: October 07, 2024 Today, the U.S. Food and Drug Administration granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test. The test, authorized for use without a prescription, is for use by …
FDA News Release Agency Continues to Support Development of Overdose Reversal Drugs including Naloxone and Nalmefene For Immediate Release: August 07, 2024 Today, the U.S. Food and Drug Administration approved Zurnai, the first nalmefene hydrochloride auto …
For Immediate Release: July 08, 2024 Today, the U.S. Food and Drug Administration is advancing its mission of ensuring the public has access to accurate, up-to-date science-based information to inform decisions about FDA-regulated medical products to …
For Immediate Release: June 27, 2024 Today, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to …
For Immediate Release: June 26, 2024 Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product …
For Immediate Release: June 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA issued a Small Entity Compliance Guide to assist small entities in complying with the …
For Immediate Release: June 21, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published final guidance titled Circumstances that Constitute Delaying, Denying, Limiting, …
FDA News Release Authorization Includes Restrictions to Mitigate Youth Risk For Immediate Release: June 21, 2024 Following an extensive scientific review, the U.S. Food and Drug Administration today authorized the marketing of four e-cigarette products in …
